FATE – Fate Therapeutics, Inc.
Fate Therapeutics, Inc.FATE
$1.15Name : Fate Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $132,629,496.00
EPSttm : -1.46
Fate Therapeutics, Inc.
$1.15
3.60%$0.04Float Short %
8.48
Margin Of Safety %
Put/Call OI Ratio
0.17
EPS Next Q Diff
0.04
EPS Last/This Y
0.53
EPS This/Next Y
0.08
Price
1.14
Target Price
4.95
Analyst Recom
2.25
Performance Q
-4.17
Relative Volume
1.09
Beta
2.22
Ticker: FATE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | FATE | 1.235 | 0.07 | 0.62 | 6450 |
| 2025-07-28 | FATE | 1.305 | 0.08 | 0.00 | 6545 |
| 2025-07-29 | FATE | 1.16 | 0.08 | 0.29 | 6629 |
| 2025-07-30 | FATE | 1.135 | 0.08 | 0.00 | 6632 |
| 2025-07-31 | FATE | 1.1 | 0.08 | 0.00 | 6739 |
| 2025-08-01 | FATE | 1.065 | 0.08 | 0.00 | 6731 |
| 2025-08-04 | FATE | 1.06 | 0.08 | 0.13 | 6735 |
| 2025-08-05 | FATE | 1.08 | 0.08 | 0.00 | 6725 |
| 2025-08-06 | FATE | 1.045 | 0.08 | 0.00 | 6725 |
| 2025-08-07 | FATE | 0.98 | 0.08 | 0.12 | 6725 |
| 2025-08-08 | FATE | 0.9207 | 0.09 | 0.00 | 6272 |
| 2025-08-11 | FATE | 0.9375 | 0.09 | 999.99 | 6497 |
| 2025-08-12 | FATE | 0.944 | 0.09 | 0.00 | 6507 |
| 2025-08-13 | FATE | 1.15 | 0.08 | 0.41 | 6464 |
| 2025-08-14 | FATE | 1.08 | 0.09 | 0.00 | 6628 |
| 2025-08-15 | FATE | 1.08 | 0.10 | 0.00 | 6217 |
| 2025-08-18 | FATE | 1.19 | 0.14 | 1.13 | 2825 |
| 2025-08-19 | FATE | 1.14 | 0.17 | 0.00 | 2979 |
| 2025-08-20 | FATE | 1.125 | 0.16 | 0.00 | 3240 |
| 2025-08-21 | FATE | 1.12 | 0.16 | 0.86 | 3254 |
| 2025-08-22 | FATE | 1.145 | 0.17 | 0.07 | 3317 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | FATE | 1.24 | -1.4 | - | -1.24 |
| 2025-07-28 | FATE | 1.30 | -1.4 | - | -1.24 |
| 2025-07-29 | FATE | 1.17 | -1.4 | - | -1.24 |
| 2025-07-30 | FATE | 1.14 | -1.4 | - | -1.24 |
| 2025-07-31 | FATE | 1.10 | -1.4 | - | -1.24 |
| 2025-08-01 | FATE | 1.07 | -4.3 | - | -1.29 |
| 2025-08-04 | FATE | 1.06 | -4.3 | - | -1.29 |
| 2025-08-05 | FATE | 1.08 | -4.3 | - | -1.29 |
| 2025-08-06 | FATE | 1.05 | -4.3 | - | -1.29 |
| 2025-08-07 | FATE | 0.98 | -4.3 | - | -1.29 |
| 2025-08-08 | FATE | 0.92 | -4.3 | - | -1.29 |
| 2025-08-11 | FATE | 0.94 | -4.3 | - | -1.29 |
| 2025-08-12 | FATE | 0.94 | -4.3 | - | -1.29 |
| 2025-08-13 | FATE | 1.13 | -4.3 | - | -1.29 |
| 2025-08-14 | FATE | 1.08 | -4.3 | - | -1.29 |
| 2025-08-15 | FATE | 1.09 | -4.3 | - | -1.12 |
| 2025-08-18 | FATE | 1.18 | 30.7 | - | -1.12 |
| 2025-08-19 | FATE | 1.14 | 30.7 | - | -1.12 |
| 2025-08-20 | FATE | 1.12 | 30.7 | - | -1.12 |
| 2025-08-21 | FATE | 1.12 | 30.7 | - | -1.12 |
| 2025-08-22 | FATE | 1.14 | 31.2 | - | -1.11 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | FATE | 0.00 | -6.36 | 8.83 |
| 2025-07-28 | FATE | 0.00 | -6.03 | 8.83 |
| 2025-07-29 | FATE | 0.00 | -6.03 | 8.83 |
| 2025-07-30 | FATE | 0.00 | -6.03 | 8.83 |
| 2025-07-31 | FATE | 0.00 | -6.03 | 8.83 |
| 2025-08-01 | FATE | 0.00 | -6.03 | 8.83 |
| 2025-08-04 | FATE | 0.00 | -7.83 | 8.83 |
| 2025-08-05 | FATE | -0.31 | -7.83 | 8.83 |
| 2025-08-06 | FATE | -0.31 | -7.83 | 8.83 |
| 2025-08-07 | FATE | -0.31 | -7.83 | 8.83 |
| 2025-08-08 | FATE | -0.31 | -7.83 | 8.83 |
| 2025-08-11 | FATE | -0.31 | -7.84 | 8.83 |
| 2025-08-12 | FATE | -0.31 | -7.84 | 8.66 |
| 2025-08-13 | FATE | -0.31 | -7.84 | 8.66 |
| 2025-08-14 | FATE | -0.31 | -7.84 | 8.66 |
| 2025-08-15 | FATE | -0.31 | -7.84 | 8.61 |
| 2025-08-18 | FATE | -0.31 | -17.13 | 8.48 |
| 2025-08-19 | FATE | -0.40 | -17.13 | 8.48 |
| 2025-08-20 | FATE | -0.40 | -17.13 | 8.48 |
| 2025-08-21 | FATE | -0.40 | -17.13 | 8.48 |
| 2025-08-22 | FATE | -0.40 | -17.13 | 8.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.29
Avg. EPS Est. Current Quarter
-0.28
Avg. EPS Est. Next Quarter
-0.24
Insider Transactions
-0.4
Institutional Transactions
-17.13
Beta
2.22
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
14
Growth Score
24
Sentiment Score
77
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.4
Target Price
4.95
P/E
Forward P/E
PEG
P/S
15.66
P/B
0.5
P/Free Cash Flow
EPS
-1.45
Average EPS Est. Cur. Y
-1.11
EPS Next Y. (Est.)
-1.03
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-2025.05
Relative Volume
1.09
Return on Equity vs Sector %
-90.3
Return on Equity vs Industry %
-77.4
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.18
EBIT Estimation
Fate Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 181
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
stock quote shares FATE – Fate Therapeutics, Inc. Stock Price stock today
news today FATE – Fate Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FATE – Fate Therapeutics, Inc. yahoo finance google finance
stock history FATE – Fate Therapeutics, Inc. invest stock market
stock prices FATE premarket after hours
ticker FATE fair value insiders trading